Yield10 Bioscience, Inc. (YTEN) Reports Q2 Loss of $0.96/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Yield10 Bioscience Announces Second Quarter 2017 Financial Results
August 10, 2017 4:05 PM EDTWOBURN, Mass., Aug. 10, 2017 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ: YTEN) today reported financial results for the three months ended June 30, 2017.
We made solid progress in the second quarter driving toward the generation of proof points in our research and development programs, commented Oliver Peoples, Ph.D., President and Chief Executive Officer. We announced the start of field tests at sites in Canada in early June for the evaluation of our novel yield trait gene C3003 in Camelina and canola. Harvest of the crops is expected to start in the... More
